Dashboard
Manage Tickers

NKGNNKGen Biotech, Inc.

Nasdaq nkgenbiotech.com


$ 0.77 $ -0.10 (-11.14 %)    

Friday, 13-Sep-2024 15:04:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 0.7736
$ 0.77 x 100
-- x --
-- - --
$ 0.73 - $ 12.88
462,209
na
27.36M
$ -0.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-12-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 07-02-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nkgen-biotech-announces-early-interim-data-from-phase-1-cohort-and-dosing-of-first-phase-2-patient-in-trial-of-troculeucel-for-moderate-alzheimers-disease-says-two-of-the-first-three-patients-in-the-phase-1-cohort-of-the-phase-12a-clinical-trial-treated-at-the-highest-dose-of-6-billion-cells-per-treatment-were-found-to-have-improved-cdr-sb-cognitive-scores-resulting-in-a-clinical-upgrade-from-moderate-ad-to-mild-ad-after-only-three-months-on-therapy
NKGen Biotech Announces Early Interim Data...
09/12/2024 12:12:41

nkgen-biotech-gets-non-compliance-notification-from-nasdaq-for-delayed-quarterly-report
NKGen Biotech Gets Non-Compliance Notifica...
08/22/2024 20:42:36

nkgen-biotech-presents-new-snk01-biomarker-data-at-the-2024-aaic-held-on-july-30-2024
NKGen Biotech Presents New SNK01 Biomarker...
07/30/2024 12:17:33

SNK01, a cryopreserved autologous non-genetically modified NK cell product, is able to effectively reduce α-synuclein (α-syn) p...

why-tellurian-shares-are-trading-higher-by-around-65-here-are-20-stocks-moving-premarket
Why Tellurian Shares Are Trading Higher By...
07/22/2024 09:24:37

why-dominos-pizza-shares-are-trading-lower-by-over-11-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Domino's Pizza Shares Are Trading Lowe...
07/18/2024 17:19:11

why-nkgen-biotech-nkgn-stock-is-skyrocketing
Why NKGen Biotech (NKGN) Stock Is Skyrocke...
07/18/2024 15:06:11

NKGen Biotech shares are trading higher by 32.5% Thursday morning. The company announced it will present new SNK01 biomarker da...

Core News & Articles
Market-Moving News for July 18th
07/18/2024 12:28:09

NKGN: 88% | NKGen Biotech Will Present New Biomarker Data On SNK01 In Alzheimer's Disease During A Poster Presentation At T...

nkgen-biotech-will-present-new-biomarker-data-on-snk01-in-alzheimers-disease-during-a-poster-presentation-at-the-upcoming-alzheimers-association-international-conference-from-july-28--august-1
NKGen Biotech Will Present New Biomarker D...
07/18/2024 12:13:44

NKGen will present data on SNK01's ability to reduce α-synuclein in Alzheimer's patients, which is significant given th...

nkgen-biotech-presents-novel-manufacturing-and-cryopreservation-process-for-allogeneic-nk-cell-therapy-snk02-ceo-dr-paul-y-song-updates-on-initial-phase-1-results-for-treating-advanced-refractory-solid-tumors
NKGen Biotech Presents Novel Manufacturing...
06/12/2024 17:07:32

nkgen-biotech-to-present-updated-phase-1-data-of-snk02-allogeneic-nk-cell-therapy-in-solid-tumors-at-6th-annual-allogeneic-cell-therapies-summit-2024
NKGen Biotech To Present Updated Phase 1 D...
06/03/2024 12:26:50

dow-falls-over-150-points-sohu-posts-q1-loss
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
05/20/2024 18:31:29

why-virios-therapeutics-shares-are-trading-lower-by-around-48-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Virios Therapeutics Shares Are Trading...
05/20/2024 17:28:52

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/20/2024 16:31:16

nasdaq-surges-100-points-wixcom-shares-jump-following-q1-results
Nasdaq Surges 100 Points; Wix.com Shares J...
05/20/2024 16:03:43

why-nkgen-biotech-stock-is-moving-higher-monday
Why NKGen Biotech Stock Is Moving Higher M...
05/20/2024 13:17:18

NKGen Biotech shares are trading higher Monday after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 tri...

Core News & Articles
Market-Moving News for May 20th
05/20/2024 12:37:59

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NK...

nkgen-biotech-announces-its-safety-review-committee-has-cleared-cos-snk01-to-progress-into-phase-2-development-in-alzheimers-disease
NKGen Biotech Announces Its Safety Review ...
05/20/2024 12:07:09

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 20:31:10

Core News & Articles
Market-Moving News for April 29th
04/29/2024 12:46:23

TSLA: 14% | Tesla shares are trading higher on reports the company will partner with Baidu for mapping and navigation for Full ...

nkgen-biotech-announces-fda-clearance-of-ind-application-for-snk01-nk-cell-therapy-in-parkinsons-disease
NKGen Biotech Announces FDA Clearance Of I...
04/29/2024 12:08:46

NKGen advances its neurodegenerative disease program with FDA IND clearance for its Phase 1/2a SNK01 Clinical Trial in patients...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION